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Alkaloids 1-4 from Cynanchum vincetoxicum (asclepiadaceae) (Scheme 1) 
do not have affinity to the oestrogen receptor but they inhibit the growth of 
the hormone-independent mammary carcinoma cells MDA-MB-231 (Fig. 
1) and bind to nucleosides and nucleotides (Table 1). Intercalation was not 
observed. 
In former times Cynanchum vincetoxicum had been used 
against mammary carcinoma1 \ First citations of this thera-
py are already found in the 6th century2). Also in medieval 
times preparations of Cynanchum vincetoxicum (ointments, 
cataplasms, lotions) had been used for the treatment of 
external breast cancer3 , 4 ). 
We wanted to know whether the alkaloids 1, 2, 3, and 4 
(Scheme 1) of this plant might contribute to the claimed 
cytostatic activity of this plant. Therefore, we tested 
whether these alkaloids 5 ) show affinity to the oestrogen 
receptor of hormone dependent mammary carcinoma 
cells 6 ' 7 ' 8 ) in comparison with [3H]-oestradiol: according to 
3 
Scheme 1 
Dedicated to Prof. Dr. / . Slavik, Brno, on the occasion of his 70th birthday. 
Alkaloide aus Cynanchum vincetoxicum: Wirkung auf MDA-MB 231 
Mammakarzinom-Zellen 
Die Alkaloide 1-4 aus Cynanchum vincetoxicum (Asclepiadaceae) (Scheme 
1) zeigen keine Affinität zum Oestrogen-Rezeptor, hemmen aber das 
Wachstum der hormonunabhängigen Mammakarzinom-Zellen M D A - M B -
231 und binden an Nukleoside und Nukleotide (Table 1). Interkalation 
wurde nicht beobachtet. 
our experiments none of these alkaloids nor the natural mix-
ture of alkaloids from C. vincetoxicum show affinity. On 
the other hand these alkaloids inhibit growth of the hor-
mone independent breast cancer cells M D A - M B 231 9 ) (Fig. 
1): Whilst Alkaloid A shows only weak activity at 1 \xM 
concentration, Alkaloid B and Alkaloid C are most effec-
tive: within the biological scattering (0.8% and 1.1%, res-
pectively) no cell growth was observed, whilst Alkaloid D 
shows T / C c o r r = 6.7% (biological scattering: 2.5%). 
In order to test whether this growth inhibition is caused by 
interaction (intercalation, e.g.) with D N A we used UV-dif-
ference spectroscopy1 0'1 1'1 2^ all the alkaloids interact with 
OCH 3 Alkaloid B 
2 
H3CO, 
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Difference spectra for 1: Ethidium bromide with native D N A ; 
2: Ethidium bromide with sonicated D N A ; 
R=[Ethidium bromide]/[DNA]=1.33. 
Difference spectra for 1:Alkaloid D with sonicated D N A ; 
2:AlkaloidD with native D N A ; 
R=[Alkaloid D]/[DNA]=1.33. 
Figure 2 
native as well as with sonicated D N A (Fig. 2). Therefore, 
intercalation cannot contribute much to this efficacy. This is 
corroborated by the negative results of ethidium bromide 
displacement1-^ (Fig. 3). 
The degree of interaction of the alkaloids with the respec-
tive DNA-nucleosides (Fig. 4) and DNA-nucleotides (Fig. 
5), however, is very different and points towards an unspe-
cific effect (Table 1). 
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Experimental Part 
UV-spectroscopy: Uvikon 810 (Kontron), tandem quartz cuvettes.- Flu-
orescence spectroscopy: Hitachi F 3000, fluorescence cuvettes.- Chroma-
tography: T L C : S i 0 2 , Merck 5554, T L C Al-foils, silica 60 F 2 5 4 . Detection: 
Dragendorff reagent (Munier/Machboef).- Column chromatography: S i 0 2 , 
Merck 7734 silica 60 (70-230 mesh).- Drying of org. phases: N a 2 S 0 4 . - A l l 
temp, in °C. 
Extraction of Alkaloids5* 
4.6 kg of coarsely milled*), dried overground parts of C. vincetoxicum 
from the surroundings of Regensburg were macerated 4 times with a total 
of 40 1 of M e O H for 24 h at room temp.- After squeezing the pertinent 
liquid was combined with the extract, evaporated in vacuo, acidified by 
dil. H C l to pH 2-3, and filtered after 12 h at 4°. In order to remove non-
# ) We thank Iso-Werk, Regensburg, for kind assistance. 
Table 1: UV-difference spectroscopy of alkaloids A , B , C, D and natural 
mixture. R 1 = [Alk.]/[Nuc] = 0.5; R 2 = [Alk.]/[Nuc] = 1.0. Values at 1 = 
260 nm. 
Nucleosid Alkaloid A Alkaloid B Alkaloid C Alkaloid D natural 
mixture 
2v-Deoxy-
adenosine 
R U 0 0 7 
R2=.113 
R!=.064 
R2=.184 
R!=.059 
R2=.063 
R!= 146 
R 2=. 116 
R!=.062 
R2=.157 
2v-Deoxy-
cytidine 
Rl=.015 
R2=.080 
Rl=.089 
R 2=089 
R!=.089 
R2=.090 
Rl=.095 
R 2=010 
Rl=.042 
R2=.230 
2^-Deoxy-
guanosine 
Rl=.064 
R2=.018 
R!=.153 
R2=.000 
Rl=.031 
R2=.171 
Rl=.031 
R 2=175 
Rl=.304 
R2=.241 
2x-Deoxy-
thymidine 
Rl=.100 
R2=.050 
Rl=.063 
R2=. 131 
Rl=.075 
R 2=059 
R!=.060 
R2=.028 
RU ( )14 
R2=.172 
2v-Deoxy-
uridine 
Rl=.014 
R2=.025 
R!=.074 
R2=.061 
R^.002 
R2=.005 
R^.110 
R2=.135 
Rl=.180 
R2=.044 
Nucleotid Alkaloid A Alkaloid B Alkaloid C Alkaloid D 
2v-Deoxy-
adenosine-5 -^
phosphate 
Rl=032 
R2=.037 
R U 0 7 5 
R2=.100 
Rl=.110 
R2=.190 
Rl=.008 
R2=.007 
2v-Deoxy-
cytidine-5v-
phosphate 
Rl=018 
R2=.084 
Rl=254 
R2=.244 
R!=.017 
R2=.146 
R U 0 3 0 
R2=.165 
2v-Deoxy-
guanosine-5v-
phosphate 
R!=.065 
R2=.020 
Rl=.020 
R2=.025 
R!=.016 
R2=.050 
Rl= 145 
R2=.010 
2x-Deoxy-
thymidine-5x-
phosphate 
R!=.020 
R2=.040 
R1-.()44 
R2=.050 
R!=.010 
R2=.180 
R U U I O 
R2=.120 
2N-Deoxy-
uridine-5N-
phosphate 
R!=.005 
R2=.050 
Rl=.080 
R2=.180 
R U 1 1 5 
R2=.200 
Rl=.005 
R2=.075 
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Difference spectra for 1: natural alkaloid mixture; R=[nat.mixture]/[2V-Deoxyguanosine]=0.5; 
2:Alkaloid B;R=[Alkaloid B]/[2V-Deoxyguanosine]=0.5; 
3:Alkaloid D;R=[Alkaloid D]/[2V-Deoxyguanosine]=0.5; 
4: Alkaloid A;R=[Alkaloid A]/[2V-Deoxyguanosine]=0.5; 
5:Alkaloid C;R=[Alkaloid C]/[2V-Deoxyguanosine]=0.5; 
Figure 4 
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Difference spectra for 1: Alkaloid A ; [R=Alkaloid A]/[2 s-Deoxy-
guanosine-5v-phosphate]=1; 
2: Alkaloid A;[R=Alkaloid A]/[2 v-Deoxy-
guanosine-5v-phosphate]=0.5; 
Figure 5 
basic materials the aqueous phase was extracted 5-6 times with half its 
volume of E t 2 0 , basified with N H 3 to pH 9, and the bases were extracted 6 
times by about 1/3 of its volume with E t 2 0 . After drying ether was remo-
ved in vacuo: 0.06% of the dry plant material were obtained as partially 
crystalline mixture of crude alkaloids.- For C C the crude alkaloids were 
dissolved in CHC1 3 and adsorbed at 4 times its weight of S i 0 2 in vacuo.-
Alkaloids 1-4 were separated using S i 0 2 and MeOH/acetone/benzene 
5/30/65. The separation process was controlled by T L C . 
Specific Rotations 
Alkaloid A: 
c = 0.10 g/100 ml MeOH; T = 24°. 
Wavelength X [nm] a t 0 ] [a][0-ml/g-dm] A[a] [O-ml /g-dm] 
589 -0.037 -37.9 -4.0 
578 -0.039 -40.0 -4.1 
546 -0.047 -48.2 -4.5 
436 -0.095 -97.4 -7.0 
Alkaloid B: 
c = 0.10 g/100 ml MeOH; T = 24° 
Wavelength X, [nm] a p ] [a] [°ml/g-dm] A[a] [°-ml/g-dm] 
589 -0.099 -94.8 -6.5 
578 -0.104 -99.0 -6.7 
546 -0.120 -114.3 -7.5 
436 -0.224 -213.3 -12.3 
Alkaloid C: 
c = 0.10 g/100 ml MeOH; T = 24° 
Wavelength X [nm] a p ] [a] [°-ml /g-dm] A[a] [°-ml /g-dm] 
589 -0.102 -103.0 -7.2 
578 -0.108 -109.1 -7.5 
546 -0.125 -126.3 -8.4 
436 -0.236 -238.4 -14.0 
Alkaloid D: 
c = 0.11 g/100 ml MeOH; T = 24° 
Wavelength X [nm] a P ] [a] [°ml/g-dm] A[a] [o-ml/g-dm] 
589 -0.021 -19.4 -2.8 
578 -0.022 -20.4 -2.8 
546 -0.025 -23.1 -3.0 
Affinity to the oestrogen receptor 
The uteri of freshly slaughtered calves were stored in ice cold physiolo-
gical NaCl solution until preparation of the cytosol. A l l preparations were 
done at 4°: the longitudinally cut horns of the uteri were freed from fat, 
parametrium, and perimetrium. Remainings of blood and mucus were 
removed by washing with physiological NaCl solution. After adding of 
tris-buffer (10 m M tris, 1.5 m M E D T A , 3 m M N a N 3 , pH 7.5) the horns 
were cut by a scissors. 10 g of tissue were suspended in 10 ml of tris-buf-
fer and homogenized (Ultraturrax, 3 times 10 s, then glass homogenizer). 
Then the homogenate was centrifuged (10 500 x g, 60 min, +4°). The clear 
supernatant was taken off by a pipette without the fatty material.- Protein 
content: 10-20 mg/ml cytosol. 
Binding affinity to the oestrogen receptor was determined indirectly 
because no radioactive inhibitor was available: According to the recom-
mendations of E O R T C 8 ) we used the charcoal adsorption technique. The 
interaction of [3H]-oestradiol, reduced by an inhibitor (run B), is compared 
with the control (no inhibitor, run A) , and the unspecifically bound amount 
of [3H]-oestradiol is determined in run C: 
solution run A run B run C 
[^HJ-oestradiol 
0.5 pM 
100 100 100 
inhibitor 100 
17ß-oestradiol 
2.0 nM 
100 
tris-buffer 300 200 200 
cytosol 100 100 100 
Runs A , B , and C were incubated at +4° for 16 h under gentle shaking. 
The non-bound amounts of [3H]-oestradiol and of inhibitor were removed 
by incubation with 0.5 ml of charcoal suspension (0.8% activated charcoal 
Norit, 0.008% dextrane in tris-buffer pH 7.5) for 1.5 h at 4°. Adsorbing 
material was removed by centrifugation (700 x g, 10 min). The determina-
tion was done in minivials: 100 ul of the supernatant were mixed with 2 
ml of scintillation liquid. The rate of bound [3H]-oestradiol was determi-
ned as the average of three measurements. The percental rate of [3H]-oe-
stradiol is plotted against the logarithm of the molar concentration of the 
inhibitor. We have chosen six concentrations of inhibitor in order to cover 
the range of 10-90% of bound [3H]-oestradiol. From the diagram, that con-
centration of inhibitor is determined which inhibits the binding of [ 3H]-
oestradiol to the receptor for 50%. The RBA-value is calculated as fol-
lows: R B A = [oestradiol] • 100/[inhibitor]; R B A o e s t r a d i o l = 100%. 
Efficacy against MDA-MB 231 cells 9 J 4 ) 
These cells have been obtained from A T C C and were cultivated as 
monolayers in dishes (Costar) in a water steam saturated atmosphere con-
taining 5% of C 0 2 . We used McCoy medium, enriched with 10% of new-
born calf serum, gentamycine (40 ug/ml) and N a H C 0 3 (2.2 g/1, pH 7.35). 
Just before confluence the cells were harvested with 0.05% trypsin -
0.02% E D T A in 0.15 M NaCl . Already a few h after distribution the cells 
continued to grow as monolayers. Cel l growth was determined by the 
mikrotitre assay: 100 ul of cell suspension/well were switched to 96-well 
mikrotitration plates. By counting under the microscope the cell density 
was determined (10-15 cells/visual field). After 2-3 days of incubation at 
37° in the atmosphere mentioned above the medium was changed at alka-
loid containing medium: to this end stock solutions of pertinent concentra-
tions were prepared, which after 1:1000 dilution by medium led to the 
desired final concentrations. 16 control wells/dish contained 0.1% of the 
solvent used for the preparation of the stock solutions. The initial cell den-
sity was determined by addition of vinblastine (10~7 M ) in 18 wells. After 
three days of incubation the medium was removed. Then 100 Jill of 1% 
glutaraldehyde in PBS were added for fixation. After 15 min the aldehyde 
solution was decanted and the affixed cells were coloured with 100 ul of 
0.02% crystal violet solution. After 25 min the dying solution was decan-
ted, the excess of crystal violet was washed off with water by suspending 
the cells for 15 min. After decanting 100 ul of 70% EtOH were added. The 
mikrotitre dishes were shaken for 1-2 h, until all the dye stuff was dissol-
ved. The optical density of the coloured solutions was determined in a 
mikrotitre dish autoreader E L 309 (Biotek) at X = 578 nm. Data were pro-
cessed on an Olivetti M 24 PC. 
Interaction of the alkaloids with DNA (UV-difference spectroscopy) 
Solutions: tris buffer p H 7.4: 12.1 g tris and 5.85 g N a C l in 700 ml 
water, N-HC1 was added for adjusting to pH 7.4, then filled up to 1 1 by 
water.- DNA-solution: 3.7 mg of calf thymus D N A type I (Sigma) were 
dissolved in 100 ml of tris buffer pH 7.4 by gentle stirring for 12 h at 4°.-
Stock solutions of test compounds: 10"2 M in D M S O . - Concentration of 
D N A was determined by measurements at 260 and 280 nm, respectively 
(content of phosphorus).- For E 2 8 0 / E 2 6 0 < 1» Lambert-Beer's law is valid: 
C D N A = E 2 6 O / € D N A • d = 0.498/6600 = 7.5 • 10"5 M 
£ D N A = 6600 M 1 (P) cm' 1 at X = 260 nm; d = 1 cm; E 2 6 0 = extinction of 
D N A solution at 260 nm. 
We used tandem cuvettes. For determination of the base line, 1 ml of 
D N A solution was pipetted into the sample cuvette, 1 ml of tris-buffer was 
given into the reference cuvette. For getting the difference spectrum 1 ul 
of alkaloid solution was added to the D N A and to the blank, respectively. 
The volume differences in both cuvettes were balanced by 1 ul of D M S O . 
After gentle mixing extinction differences were determined between 550 
and 230 nm. The quotient [alkaloid]/[DNA] is plotted against the extinc-
tion. A linear increase points towards a dependence on the concentration. 
Interaction with sonicated DNA 
In order to destroy the D N A structure, the D N A solutions (vide supra) 
were sonicated for 10 min at room temp. The UV-difference spectra of 
native and sonicated D N A were compared. 
Interactions with phosphorylated and non-phosphorylated DNA-incre-
ments 
Instead of D N A solutions stock solutions of the nucleosides 2'-deoxya-
denosine, 2'-deoxycytidine, 2'-deoxyguanosine, 2'-deoxythymidine, and 
2'-deoxyuridine or of the corresponding nucleotides were used. The base 
line was determined analogously (vide supra) using 5 ul of nucleoside- or 
nucleotide stock solution, respectively. Consequently 5 ul of D M S O were 
needed for volume balance. The difference spectra were determined using 
2.5 and 5 ul of test solutions added to the nucleosides or nucleotides, re-
spectively.- Determination parameters: scan: 550-230 nm; speed: 100 
nm/min; zero suppression: -0.4; recorder scale: 0.8; chart speed: 10 
cm/min. 
Ethidium bromide displacement 
The methodology of LePecqU) was used.- Excitation: 546 nm, emission: 
590 nm.- Tris-buffer pH 7.4 and DNA-solution: vide supra.- Concentration 
of DNA-solution (determination at 260 nm): 7.56 • 10"5 M (P).- Ethidium 
bromide stock solution: 10"2 M in D M S O . - Control: actinomycin D, 10"2 
M in D M S O . - Test substances: alkaloids 1-4. 
1 ml of ethidium bromide solution - [DNA]/[Ethidium bromide] = 1.5 -
was pipetted into the fluorescence cuvette and the maximal fluorescence 
(100%) was determined. After addition of varying amounts of alkaloid 
solution (1-5 ul) or actinomycin D, respectively, the solutions were mixed 
gently and the fluorescence was determined (mean value of three determi-
nations). For graphic evaluation the molar ratio [substance]/[DNA] or the 
added quantity of test substance [ul], respectively, is plotted against the 
fluorescence intensity [%].- Parameters: excitement wavelength: 546 nm; 
emission wavelength: 590 nm; excitement bandpass: 5 nm; emission band-
pass: 5 nm. 
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